Michael J. McElhaugh
2023
In 2023, Michael J. McElhaugh earned a total compensation of $1.6M as Current Interim President and Chief Executive Officer at Arbutus Biopharma Corp, a 23% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $144,900 |
|---|---|
| Option Awards | $733,355 |
| Salary | $483,000 |
| Stock Awards | $242,730 |
| Other | $16,500 |
| Total | $1,620,485 |
McElhaugh received $733.4K in option awards, accounting for 45% of the total pay in 2023.
McElhaugh also received $144.9K in non-equity incentive plan, $483K in salary, $242.7K in stock awards and $16.5K in other compensation.
Rankings
In 2023, Michael J. McElhaugh's compensation ranked 702nd out of 2,790 executives tracked by ExecPay. In other words, McElhaugh earned more than 74.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 702 out of 2,790 | 75th |
Division Manufacturing | 404 out of 1,530 | 74th |
Major group Chemicals And Allied Products | 276 out of 869 | 68th |
Industry group Drugs | 270 out of 832 | 68th |
Industry Pharmaceutical Preparations | 176 out of 597 | 71st |
Source: SEC filing on April 10, 2024.
McElhaugh's colleagues
We found three more compensation records of executives who worked with Michael J. McElhaugh at Arbutus Biopharma Corp in 2023.